Explore how artificial intelligence is transforming cardiovascular care through real-world application in ATTR-CM detection. This course equips clinicians with insights into AI-driven tools for risk assessment and diagnosis while addressing ethical considerations and promoting patient-centered care. Enhance your clinical decision-making by learning to partner effectively with emerging technology.
Learning Objectives
- Discuss the supportive role of AI-driven tools in cardiovascular disease risk assessment, testing, diagnosis and monitoring
- Review considerations such as data privacy, bias in AI algorithms and strategies for integrating patient-centered approaches with AI-assisted care approaches
- Examine a case study of AI-augmentation in transthyretin amyloid cardiomyopathy (ATTR-CM) detection and diagnosis highlighting the partnership of clinician expertise with AI-driven technology
CE certificate available upon successful completion of the post-test and program evaluation.
BSN, RN
Accreditation:
PCNA is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 030602. This activity is approved for 0.75 contact hour(s).
